Tatva Chintan Pharma Chem - Ex-Structure Directing Agent Portfolio Facing Demand Headwinds: Nirmal Bang. We visited Dahej special economic zone plant of Tatva Chintan Pharma Chem Ltd. after commercialisation of the new capacity (capex Rs 1.5 billion) and interacted with the management. While SDAs are expected to grow in FY24 on a favorable base, ex-structure directing agent portfolio is under pressure due to subdued demand and pricing as most of customers are cutting down inventory levels. Prices of select key raw material are back to 1998 levels, as per management. After ~50% cut in majority of the basket over last six months, prices are expected to stabilise at current levels.
International Zeolite Corp. and CoTec Holdings Corp. announced that CoTec agreed to make a USD 2 million strategic investment in IZ to support its go-to-market activities in the agricultural and green tech segments. The investment from CoTec is expected to fast-track IZ's ability to move rapidly to full commercialization, marketing, and sales capabilities for its disruptive agricultural products and solutions.
Author Credits: Smruti Ranjan, Rajrani Baghel
Report ID: 5464
Published Date: Dec 21, 2023
Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
Growing demand for automotive and the development of new and advanced techniques are the major factors driving the growth of the structure directing agents market.
The market size of structure directing agents is anticipated to attain a CAGR of 8% over the forecast period, i.e., 2024-2036.
The major players in the market are TatvaChintan Pharma Chem Private Limited, Merck KGaA, Otto ChemiePvt Ltd, Alfa Aesar, BASF SE, Clariant AG, Sasol Limited, and others.
The crystalline materials segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.
The market in the North America region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.